Exec Fired For Questioning Ortho Evra Safety?

Staff Writer
Contributor
Posted by Staff WriterDecember 23, 2006 12:31 PM

Dr. Joel S. Lippman, former VP at two subsidiaries of Johnson & Johnson, claims he was fired for questioning the safety of Ortho Evra, among other faulty products. Johnson & Johnson claims Dr. Lippman was fired for improper conduct, but the former exec says he was terminated for repeatedly raising safety concerns and asking that products be recalled or not launched at all.

The lawsuit alleges Lippman's problems with his employer began when he complained about inadequate safety data on a hormonal menopausal product called Ortho-Prefest and about serious health concerns over the Ortho Evra patch, "which released dangerously high levels of estrogen into patients."

This September, the Food and Drug Administration required J&J to add a warning to the Ortho Evra package insert stating the risk of dangerous blood clots in the legs and lungs may be higher for women on the patch instead of birth-control pills.

As of October 1st, there were over 1000 lawsuits pending with women claiming injuries from Ortho Evra. Some women have died of blood clots while using the drug.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Toledo

InjuryBoard Toledo RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address